Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens [Phase 3]
This clinical trial update reports the completion and posting of results for TBTC Study 31, a Phase 3 trial evaluating rifapentine-containin…
-
FDA approval · 2021-09-23FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) from Janssen Products, LP.
-
CLINICAL_TRIALS withdrawal · 2021-09-20Clinical Trial Update: A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects [Phase 4]
A Phase 4 pharmacokinetic/pharmacodynamic study evaluating interactions between bictegravir, tenofovir alafenamide, and rifapentine in healt…
-
FDA approval · 2021-09-14FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Rifampin under the ANDA. The approval indicates changes to the Rifampin pro…
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Rifampin (RIFAMPIN) submitted by Chartwell RX, LLC under ANDA065390.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (EPIC PHARMA, LLC)
The FDA approved a supplemental application for Rifampin from Epic Pharma, LLC. The action pertains to changes under the Rifampin ANDA 06415…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Infant TB Infection Prevention Study [Phase 2]
Phase 2 clinical trial update for an infant TB infection prevention study; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis [Phase 4]
Phase 4 trial comparing wirelessly observed therapy to directly observed therapy for tuberculosis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: DAR-901 TB Booster Vaccine to Prevent TB in Adolescents [Phase 2]
Phase 2 trial results for DAR-901 TB booster vaccine in adolescents completed; study posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study) [Phase 3]
Phase 3 trial assessing accuracy and consequences of using trial-of-antibiotics for diagnosing tuberculosis.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi [Phase 2, Phase 3]
Phase 2/3 clinical trial update on male partner-assisted contact tracing for HIV and tuberculosis in Malawi; trial status terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Rifampicin at High Dose for Difficult-to-Treat Tuberculosis [Phase 2]
Phase 2 clinical trial examining high-dose rifampicin for difficult-to-treat tuberculosis is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis [Phase 2, Phase 3]
Phase 2/3 trial evaluating cyclophosphamide for refractory proliferative arachnoiditis in CNS tuberculosis is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB [Phase 1, Phase 2]
Phase 1/2 trial assessing safety, tolerance, and pharmacokinetics of raltegravir-containing ART in infants and children with HIV and tubercu…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia [Phase 2]
Phase 2 pharmacokinetic interaction study in Indonesian tuberculosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region [Phase 2]
Phase 2 trial assessing immunogenicity and safety of a TB vaccine candidate in healthy adults in a TB-endemic region; study completed.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy) [Phase 3]
Phase 3 trial of recombinant ESAT6-CFP10 allergen for tuberculosis in healthy adults completed.
-
FDA approval · 2020-09-02FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's supplemental application for rifampin (RIFAMPIN).
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection [Phase 1]
Phase 1 trial update comparing MVA85A aerosol vs intramuscular vaccination in adults with latent TB infection; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis [NA]
A completed clinical trial evaluating the effects of a protein-calorie supplement in HIV-infected women with tuberculosis; results posted in…
-
FDA approval · 2020-08-17FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Rifampin from Lupin Pharmaceuticals, approving an addition or change to the existing Rifampin pr…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients [Phase 3]
Phase 3 trial comparing efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV/TB co-infected patients; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis [Phase 2]
Phase 2 clinical trial update evaluating 14-day early bactericidal activity of nitazoxanide for tuberculosis treatment has completed.
-
FDA approval · 2020-07-27FDA Approved: PYRAZINAMIDE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved a generic version of pyrazinamide under an original application filed by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy [Phase 2]
Phase 2 trial comparing two doses of NVP (nevirapine) after initiating rifampin-containing TB therapy completed.